Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

COSCIENS Biopharma Inc T.AEZS

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:AEZS - Post by User

Post by Hopeforthebeston Jun 15, 2024 1:45am
239 Views
Post# 36090318

Re: How to launch a new company

Re: How to launch a new company

Well another failure can be contributed to gagnon, the Nasdqa has has five records highs of in a row, meanwhile the new AEZS looks like quadruple black diamond run and steep at that, down, down, and down not only 5 days in a row but the entire days day since the shammed merger of equals. 

it is evident that gagnon's failures which are many are well known in the market as no one is willing to  support this company, even I'm am thrill ( still collecting money) NoShowRonnie has failed to show up and provide support to gagnon. His name is synonymous with failure , misleading promises and missed deadlines that is draining the coffers at a critical rate of $5,000,000 plus per quarter.
 

<< Previous
Bullboard Posts
Next >>